Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intercalating Gefitinib with Chemotherapy in EGFR+ NSCLC
NCT02299765Phase 4Terminated
- Sponsor
- Sichuan University
- Start
- Dec 2014
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gefitinib in non-small cell lung cancer (NSCLC), sponsored by Sichuan University. Started Dec 2014; status: terminated.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02299765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299765.